|
|
UCSD-Nature Molecule Pages
Published online: 8 Aug 2006 | doi:10.1038/mp.a002273.01
TGF-beta type II receptor
Nadine Hempel1, Gerard C Blobe1
1Medicine and Pharmacology, Duke University Medical Center, NC 27710, US.
Correspondence should be addressed to Gerard C Blobe: blobe001@mc.duke.edu

Transforming growth factor β (TGFβ) is a polypeptide cytokine that has a vital role in regulating cellular proliferation and differentiation, as well as tissue specific processes including angiogenesis and wound healing. The type II TGFβ receptor (TβRII) is a constitutively active cell surface serine/threonine kinase receptor. The TGFβ isoform homodimers either directly bind to TβRII or are presented to TβRII by the accessory type III TGFβ receptor (TβRIII, betaglycan). TβRII has affinity for TGF-β1 and TGF-β3 isoforms but requires TβRIII to bind TGF-β2. Upon ligand binding, TβRII forms a complex with TβR1 (ALK-5) and phosphorylates the juxtamembrane GS domain of TβRI to activate its serine/threonine kinase. In turn, the receptor activated transcription factors Smad 2 and Smad 3 are phosphorylated by TβRI. Phosphorylated Smad2/Smad3 then bind Smad4 and translocate to the nucleus to enable interaction with other transcription factors and regulate the transcription of TGFβ responsive genes. In endothelial cells, upon ligand binding, TβRII can also form a complex with and activate ALK-1, which then phosphorylates Smads (Smads 1/5/8) to mediate a distinct signaling pathway.
Alternative names for this molecule:
HNPCC6; TbetaR-II; TbetaRII; TGF-beta RII; TGF-beta type II receptor; Tgfbr2; Transforming growth factor, beta receptor II; Transforming growth factor, beta receptor II (70/80kDa)
|
|
|